Baird Medical Investment Holdings (BDMD) Cash & Equivalents (2023 - 2025)

Baird Medical Investment Holdings (BDMD) has reported Cash & Equivalents for 3 consecutive years, with $387496.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash & Equivalents fell 86.95% year-over-year to $387496.0; the TTM figure through Dec 2025 stood at $387496.0 (down 86.95% YoY), while the FY2025 annual figure was $387496.0, down 86.95% from the prior year.
• Cash & Equivalents fell to $387496.0 in Q4 2025 per BDMD's latest filing, from $2.2 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $3.0 million in Q4 2024 and bottomed at $387496.0 in Q4 2025.
• Historically, Cash & Equivalents has averaged $1.8 million across 3 years, with a median of $1.8 million in 2023.
• Annual changes were most pronounced in 2024 — Cash & Equivalents jumped 96.64% — and 2025, when it tumbled 86.95%.
• Baird Medical Investment Holdings' Cash & Equivalents stood at $1.5 million in 2023, then surged by 96.64% to $3.0 million in 2024, then sank by 86.95% to $387496.0 in 2025.
• Business Quant data shows BDMD's Cash & Equivalents at $387496.0 in Q4 2025, $2.2 million in Q2 2025, and $3.0 million in Q4 2024.